We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET Imaging More Effective than Angiogram for Determining Need for Coronary Stents or Bypass Surgery

By MedImaging International staff writers
Posted on 01 Dec 2022
Print article
Image: PET imaging technology used to map coronary blood flow and its outcomes in heart disease patients (Photo courtesy of UTHealth Houston)
Image: PET imaging technology used to map coronary blood flow and its outcomes in heart disease patients (Photo courtesy of UTHealth Houston)

Most forms of heart disease cause myocardial damage. Myocardial ischemia occurs when blood flow to the heart is reduced, preventing the heart muscle from receiving enough oxygen. When myocardial ischemia affects the deep, or subendocardial, layer of the left ventricular muscle, it is known as subendocardial ischemia. Subendocardial ischemia is commonly diagnosed in patients with cardiovascular disease, but it is not quantified by current imaging tools. The angiogram – an X-ray test that helps doctors evaluate blockages in the arterial system – shows how to do stents or bypass surgery, but not whether those procedures should be done at all.

Now, researchers at The University of Texas Health Science Center at Houston (Houston, TX, USA) have used positron emission tomography (PET) imaging technology to map coronary blood flow and its outcomes – namely, subendocardial ischemia – among patients with heart disease. The new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to the researchers. The latest study confirmed the findings of their previous research by proving the PET threshold of severity at which stents and bypass surgery improve survival compared to medical treatment alone.

“The cumulative data reveals that all randomized trials of coronary stents and bypass surgery have failed to improve survival after revascularization due to profoundly flawed patient selection based on the angiogram,” said K. Lance Gould, MD, professor and the Martin Bucksbaum Distinguished University Chair in Heart Disease with McGovern Medical School at UTHealth Houston, who was first author on the study and led the team of researchers. “Thus, the coronary angiogram is not the gold standard for determining stents or bypass surgery, but rather, quantitative myocardial perfusion by PET is the gold standard.”

Related Links:
UTHealth Houston

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Catheter Connector Cover
ACUSON AcuNav
New
Silver Member
Radiographic Positioning Equipment
2-Step Multiview Positioning Platform
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80

Print article
Radcal

Channels

Radiography

view channel
Image: 3D cinematic renderings of the control and diseased heart in anatomic orientation (Photo courtesy of ESRF)

Innovative X-Ray Technique Captures Human Heart with Unprecedented Detail

Cardiovascular disease remains the leading cause of death globally. In 2019, ischemic heart disease, which weakens the heart due to reduced blood supply, accounted for approximately 8.9 million or 16%... Read more

MRI

view channel
Image: SubtleSYNTH creates synthetic STIR images with zero acquisition time that are interchangeable with conventionally acquired STIR images (Photo courtesy of Subtle Medical)

AI-Powered Synthetic Imaging Software to Further Redefine Speed and Quality of Accelerated MRI

The development of innovative solutions is not only redefining the landscape of artificial intelligence (AI)-based diagnostic imaging but also simplifying the ever-increasing complexity of workflows faced... Read more

Ultrasound

view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The new collaborations aim to further advance AI foundation models for medical imaging (Photo courtesy of Microsoft)

Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging

Medical imaging is a critical component of healthcare, with health systems spending roughly USD 65 billion annually on imaging alone, and about 80% of all hospital and health system visits involve at least... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.